Fighting the Generics Next Door
641808
Pfizer tries to stop patients from switching to generic Zocor.
527105
After years of churning out cheap copycat drugs for the home market, Indian pharmaceutical firms are trying their hand at researching new drugs as they seek fresh revenue streams to cement their long-term survival.
212028
Drug companies rushing to fill the vacuum left by Merck &amp; Co.&#39;s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing
411558
The pharmaceutical sues over patent infringement.
65390
HOW MANY PILLS are you taking? Until the Vioxx scare, it wasn&#39;ta question that bothered many. Now with Celebrex and even generic naproxen joining the list of questioned meds, it&#39;s a timely inquiry.
214179
WASHINGTON -- Some influential members of Congress are renewing their pledge to help speed generic versions of the world's most expensive drugs to market.
130395
Critics charge conflict of interest in a system where pharmaceutical giants fund the regulatory process. By Alexandra Marks | Staff writer of The Christian Science Monitor.
416882
Competition for painkiller patch may prove to be a major pain for the generics maker.
653155
Changes to Medicare have many seniors in a tailspin. Prescription drug cards, managed care, Medigap, Part B -- they can&#39;t sort it out on their own, and the constant barrage of targeted advertisements and slick-sounding come-ons don&#39;t help.
709830
Encysive gets set for a showdown with the FDA.
372947
Stocks of branded and generic drug makers closed down a bit Tuesday as clinical study results mixed with merger updates. One of the big winners on the day was Nektar Therapeutics, on news that Exubera, the
617753
Cheaper versions of biologic drugs can be made safely, a U.S. Senate panel heard on Thursday, but brand-name makers of the pricey therapies for cancer and other diseases warned substitutes could be risky.
364598
Wal-Martâs expansion of its low-cost generic drug program indicates that the company is reaching out to a younger and broader clientÃ¨le.
438616
The makers of such insecticides as Raid and Off are taking a swat at what they consider a new nuisance in the neighborhood: nontoxic, botanical pesticides that are ratcheting up competition in the war on bugs.
732377
The companies decide to play nice over generic versions of two of Pfizer's drugs.
64536
Whether it's the latest miracle ab exerciser, a get-rich-quick scheme or a weight-loss supplement, many of those call-now-and-order products hyped on infomercials and TV shopping networks are nothing more than tacky junk. Separating the rip-offs from the useful gadgets isn't always easy.
681991
The newly empowered Democrats' vow to cut healthcare costs might spell bad news for the brand-name pharmaceutical industry, but could provide new momentum for generic drug rivals, the Wall Street Journal reported on its Web site on Tuesday.